Advertisement

International Urogynecology Journal

, Volume 30, Issue 3, pp 483–488 | Cite as

The proportion of women with central sensitivity syndrome in gynecology outpatient clinics (GOPDs)

  • Monika VijEmail author
  • Anthony Davies
  • Anu Dua
  • Robert Freeman
Original Article
  • 159 Downloads

Abstract

Introduction and hypothesis

Patients in gynecology outpatient clinics (GOPDs) may present with symptoms that do not correlate well with the observed pathology and are usually labelled as having a functional disorder or medically unexplained symptoms (MUS). Underlying central sensitivity syndrome (CSS) with central sensitization (CS) as a potential mechanism may be responsible for some of their symptoms. The aim of this study is to identify the proportion of women with central sensitivity syndrome attending GOPDs.

Methods

This was a prospective study. All women attending a GOPD included in the study were asked to complete a validated Central Sensitization Inventory (CSI). The responses were graded on a Likert scale from 0 (never) to 4 (always). The total score ranges from 0 to 100. For screening purposes, a single CSI cutoff score of 40 was used to identify the group of women who may have central sensitization syndrome.

Results

Three hundred twenty-six women participated in the study. Overall, 123 (37%) women achieved a score above 40. This could be interpreted as these patients having increased risk of underlying central sensitization. Of these, 43 had a previously confirmed diagnosis of migraine, 55 (44%) depression, 39 (31.7%) anxiety, 11 fibromyalgia (FM), 34 irritable bowel syndrome (IBS) and 16 chronic fatigue syndrome (CFS/ME).

Conclusions

Managing patients and their expectations in gynecological outpatient departments when symptoms are inconsistent with observable pathological findings is challenging. This is further complicated when patients have a concomitant central sensitivity syndrome, which can also influence the surgical outcome. Identifying these patients is a key factor for appropriate management.

Keywords

Central sensitivity syndrome Central sensitization Pelvic organ prolapse Gynecology outpatient clinic 

Notes

Compliance with ethical standards

Conflicts of interest

Monika Vij: none.

Dr. Anthony Davies: none.

Anu Dua: Honoraria, Speciality European Pharma.

Robert Freeman: Honoraria, holds a position on the IUGA Board

References

  1. 1.
    Ninham C, Hotopf M, Wessely S. Medically unexplained symptoms: and epidemiological study in seven specialties. J Psychosom Res. 2001;51:361–7.CrossRefGoogle Scholar
  2. 2.
    Yunus MB. Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness. Semin Arthritis Rheum. 2008;37(6):339–52.CrossRefPubMedGoogle Scholar
  3. 3.
    Mayer TG, Neblett R, Cohen H, Howard KJ, Choi YH, Williams MJ, et al. The development and psychometric validation of the central sensitization inventory. Pain Pract. 2012;12:276–85.CrossRefPubMedGoogle Scholar
  4. 4.
    Neblett R, Cohen H, Choi Y, Hartzell M, Williams M, Mayer TG, et al. The central sensitisation inventory (CSI): establishing clinically significant values for identifying central sensitivity syndromes in an outpatient chronic pain sample. J Pain. 2013;14(5):438–45.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Engel GL. The need for a new medical model: a challenge for biomedicine. science. 1977;196(4286):129–36.CrossRefPubMedGoogle Scholar
  6. 6.
    Bourke JH, Langford RM, White PD. The common link between functional somatic syndromes may be central sensitisation. J Psychosom Res. 2015;78(3):228–36.CrossRefPubMedGoogle Scholar
  7. 7.
    Sharpe M. Somatic symptoms: beyond medically unexplained. Br J Psychiatry. 2013;203(5):320–1.CrossRefPubMedGoogle Scholar
  8. 8.
    Yunus MB. Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes. Semin Arthritis Rheum. 2007;36(6):339–56.CrossRefPubMedGoogle Scholar
  9. 9.
    Adams K, Osmundsen B, Thomas Gregory W. Does fibromyalgia influence symptom bother from pelvic organ prolapse? Journal. 2014;25(5):677–82.Google Scholar
  10. 10.
    Kim SH, Yoon KB, Yoon DM, Yoo JH, Ryang K. Influence of centrally mediated symptoms on postoperative pain in osteoarthritis patients undergoing total knee arthroplasty: a prospective observational evaluation. Pain Pract. 2015;15(6):E46–53.CrossRefPubMedGoogle Scholar
  11. 11.
    Creed FH, Davies I, Jackson J, et al. The epidemiology of multiple somatic symptoms. J Psychosom Res. 2012;72:311–7.CrossRefPubMedGoogle Scholar
  12. 12.
    Barsky AJ, Ettner SL, Horsky J, Bates DW. Resource utilization of patients with hypochondriacal health anxiety and somatization. Med Care. 2001;39:705–15.CrossRefPubMedGoogle Scholar
  13. 13.
    Shraim M, Mallen CD, Dunn KM. GP consultations for medically unexplained physical symptoms in parents and their children: a systematic review. Br J Gen Pract. 2013;63:e318–25.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Fink P. Surgery and medical treatment in persistent somatising patients. J Psychosom Res. 1992;36(5).Google Scholar
  15. 15.
    Warren JW, Morozov V, Howard FM, Wesselmann U, Gallicchio L, Langenberg P, et al. Before the onset of interstitial cystitis/bladder pain syndrome, the presence of multiple non- bladder syndromes is strongly associated with a history of multiple surgeries. J Psychosom Res. 2014;76(1):75–9.CrossRefPubMedGoogle Scholar
  16. 16.
    Flynn TW, Smith B, chou R. Appropriate use of diagnostic imaging in low back pain: a reminder that unnecessary imaging may do as much harm as good. J Orthop Sports Phys Ther. 2011;419110:838–46.CrossRefGoogle Scholar
  17. 17.
    Gwilym SE, Oag HC, Tracey I, Carr AJ. Evidence that central sensitisation is present in patients with shoulder impingement syndrome and influences the outcome after surgery. J Bone Joint Surg Br. 2011;93(4):498–502.CrossRefPubMedGoogle Scholar
  18. 18.
    Kregel J, Vuijk PJ, Descheemaeker F, Keizer D, van der Noord R, Nijs J, et al. The Dutch central sensitization inventory (CSI): factor analysis, discriminative power and test-retest reliability. Clin J Pain. 2015.  https://doi.org/10.1097/AJP.0000000000000306.
  19. 19.
    Choi Y. An examination of the validity of the central sensitisation inventory with chronic disabling occupational musculoskeletal disorders. Presented to the Faculty of the Graduate School of the University of Texas at Arlington in Partial Fulfilment of the Requirements for the Degree of Doctor of Philosophy, The University of Texas at Arlington. 2013.Google Scholar

Copyright information

© The International Urogynecological Association 2018

Authors and Affiliations

  1. 1.Derriford HospitalPlymouthUK
  2. 2.Singleton HospitalSwanseaUK

Personalised recommendations